Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04674345
What this trial is testing

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Who this might be right for
Acute LeukemiaRelapseHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 346
Not applicableLooking for participantsNCT06455332
What this trial is testing

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 200
Testing effectiveness (Phase 2)Looking for participantsNCT05849857
What this trial is testing

Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

Who this might be right for
Lymphoma, Follicular
Oslo University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00781898
What this trial is testing

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

Who this might be right for
Opiate Addiction
University of Pennsylvania 308
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01963234
What this trial is testing

Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)

Who this might be right for
Substance Use DisordersHIV
University of Wisconsin, Madison 439
Testing effectiveness (Phase 2)Study completedNCT00708292
What this trial is testing

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Novartis Pharmaceuticals 29
Early research (Phase 1)Study completedNCT00780702
What this trial is testing

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

Who this might be right for
Cocaine DependenceCocaine-Related DisordersOpioid-Related Disorders
National Institute on Drug Abuse (NIDA) 41
Not applicableStudy completedNCT04238130
What this trial is testing

Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 132
Testing effectiveness (Phase 2)Study completedNCT00083902
What this trial is testing

Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 190
Testing effectiveness (Phase 2)Looking for participantsNCT06383572
What this trial is testing

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

Who this might be right for
Lymphodepleting ChemotherapyMyeloid Malignancies
M.D. Anderson Cancer Center 44
Early research (Phase 1)Study completedNCT01525628
What this trial is testing

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 72
Testing effectiveness (Phase 2)Study completedNCT03752307
What this trial is testing

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

Who this might be right for
Multiple Sclerosis
University of New Mexico 2
Testing effectiveness (Phase 2)Study completedNCT00218075
What this trial is testing

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

Who this might be right for
Cocaine AbuseCocaine-Related Disorders
The University of Texas Health Science Center, Houston 200
Not applicableUnknownNCT02075957
What this trial is testing

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Angers 192
Testing effectiveness (Phase 2)Study completedNCT00286780
What this trial is testing

Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Ascenta Therapeutics 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Not applicableActive Not RecruitingNCT06145594
What this trial is testing

EMA-Guided Maintenance TMS for Depression

Who this might be right for
Major Depressive Disorder
Butler Hospital 30
Not applicableLooking for participantsNCT04587856
What this trial is testing

Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto 38
Next Page